4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001213900-25-019673
Options or other derivatives
- Chief Scientific Officer acquired 139,273 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Reich Kristian Chief Scientific Officer | 2025-02-27 | Grant or award · Stock Option (Right to Buy) | +139,273 | 139,273 | D: show line 1 in the form |
Loading xslF345X05/ownership.xml…